1. Home
  2. SOLS vs BMRN Comparison

SOLS vs BMRN Comparison

Compare SOLS & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SOLS

Solstice Advanced Materials Inc.

N/A

Current Price

$77.51

Market Cap

11.9B

Sector

Industrials

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$56.18

Market Cap

10.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOLS
BMRN
Founded
2025
1996
Country
United States
United States
Employees
4400
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
10.9B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
SOLS
BMRN
Price
$77.51
$56.18
Analyst Decision
Buy
Buy
Analyst Count
4
18
Target Price
$72.75
$88.22
AVG Volume (30 Days)
1.9M
1.7M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
0.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.80
Revenue
N/A
$1,313,646,000.00
Revenue This Year
$6.46
$14.30
Revenue Next Year
$5.46
$11.65
P/E Ratio
$54.31
$31.23
Revenue Growth
N/A
17.62
52 Week Low
$40.43
$50.76
52 Week High
$84.44
$66.28

Technical Indicators

Market Signals
Indicator
SOLS
BMRN
Relative Strength Index (RSI) 56.46 47.47
Support Level $69.12 $56.32
Resistance Level $83.07 $60.06
Average True Range (ATR) 3.39 1.29
MACD 0.31 0.18
Stochastic Oscillator 80.78 73.34

Price Performance

Historical Comparison
SOLS
BMRN

About SOLS Solstice Advanced Materials Inc.

Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: